What is the treatment for pyelitis (inflammation of the renal pelvis)?

Pyelonephritis: Definition and Treatment

What is Pyelonephritis?

Pyelonephritis is a bacterial infection involving both the renal pelvis and the kidney parenchyma itself, most commonly caused by Escherichia coli ascending from the lower urinary tract. 1, 2

• The infection typically spreads upward from the bladder through contamination with intestinal and genital skin flora 3
• Peak incidence occurs in women aged 15-65 years, though it affects all ages and both sexes 2, 3
• Clinical presentation includes fever (though may be absent early), flank pain (nearly universal), and laboratory evidence of urinary tract infection 2, 4

---

Treatment Approach

Initial Diagnostic Steps

Obtain urine culture with antimicrobial susceptibility testing in all patients before initiating antibiotics to guide therapy if empiric treatment fails. 1, 4

• Urinalysis confirms diagnosis when combined with compatible history and flank pain 2
• Blood cultures and imaging are unnecessary in uncomplicated cases 4
• Imaging (contrast-enhanced CT) is reserved for patients not improving within 48-72 hours or those with symptom recurrence 1, 2

Outpatient Treatment (Uncomplicated Cases)

For mild-to-moderate uncomplicated pyelonephritis, oral fluoroquinolones are first-line therapy if local resistance rates are ≤10%. 1, 2, 4

Recommended oral regimens:

• Ciprofloxacin 500-750 mg twice daily for 7 days 1, 5, 2
• Levofloxacin 750 mg once daily for 5 days 1, 5, 2

Critical caveat: If local fluoroquinolone resistance exceeds 10%, give one initial IV dose of ceftriaxone 1-2 g, then switch to oral fluoroquinolone while awaiting culture results 1, 5, 2, 4

Alternative oral options (less preferred):

• Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 14 days—only if susceptibility is confirmed 1, 5
• Oral β-lactams (cefpodoxime 200 mg twice daily for 10 days or ceftibuten 400 mg once daily for 10 days) have lower efficacy than fluoroquinolones 5

Avoid these agents for pyelonephritis: Nitrofurantoin, oral fosfomycin, and pivmecillinam lack sufficient efficacy data for upper tract infections 1, 5

Inpatient Treatment (Severe or Complicated Cases)

Hospitalize patients with severe illness, suspected complications (obstruction, abscess), sepsis, immunocompromise, diabetes, pregnancy, or inability to tolerate oral therapy. 1, 2, 4

Initial IV empiric therapy options:

• Ciprofloxacin 400 mg IV every 12 hours 6, 7
• Levofloxacin 750 mg IV daily 6, 7
• Ceftriaxone 1-2 g IV daily (use 2 g for sepsis) 6, 7
• Cefepime 2 g IV every 12 hours 6
• Piperacillin/tazobactam 2.5-4.5 g IV every 8 hours 6, 7

For septic patients or those at risk for multidrug-resistant organisms:

• Add gentamicin 5 mg/kg IV daily to cephalosporins initially, then de-escalate to monotherapy after 48-72 hours based on cultures 6
• Reserve carbapenems (meropenem 1 g IV every 8 hours) and novel β-lactam/β-lactamase inhibitor combinations for confirmed ESBL-producing organisms or known colonization 6, 5

Critical Management Principles

Initiate antibiotics within the first hour after diagnosis in patients with urosepsis. 6

If urinary obstruction is present, urgent decompression is critical for survival and must be performed immediately. 6, 4

• Obtain two sets of blood cultures and urine culture before administering antibiotics 6
• Perform urgent imaging to identify obstruction or abscess before starting treatment 6
• Narrow therapy to the most specific effective agent within 48-72 hours based on culture results 6

Special Populations

Pregnant patients with pyelonephritis require hospital admission and initial parenteral therapy due to significantly elevated risk of severe complications. 4

Diabetic patients warrant special attention:

• Higher vulnerability to complications including emphysematous pyelonephritis and abscess formation 1
• Up to 50% lack typical flank tenderness, making clinical diagnosis more difficult 1

Treatment Duration and Follow-up

Most patients respond within 48-72 hours; those who do not require repeat imaging and cultures while considering alternative diagnoses. 4

• Treatment duration ranges from 5-14 days depending on antibiotic choice and clinical response 5
• Routine post-treatment urinalysis or cultures are unnecessary in asymptomatic patients 1
• For symptoms persisting beyond treatment or recurring within 2-4 weeks, obtain urine culture and assume resistance to the initial agent 1

Common Pitfalls to Avoid

Do not use oral β-lactams or trimethoprim-sulfamethoxazole empirically due to high resistance rates in most communities. 2, 4

Avoid delaying source control—if clinical deterioration occurs, perform imaging immediately rather than waiting 72 hours. 6

Do not use fluoroquinolones empirically if local resistance exceeds 10% without giving initial parenteral broad-spectrum coverage. 6, 2, 4